Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BioNTech : Plans Development of First mRNA-Based Malaria Vaccine

07/26/2021 | 03:01pm EDT


© MT Newswires 2021
All news about BIONTECH SE
09/24ADRs End Lower; WPP, BioNTech Among Companies Actively Trading
DJ
09/24Equities Fluctuate Midday as Real Estate, Tech Among Worst Performers
MT
09/24WALGREENS BOOTS ALLIANCE : Who can get a COVID-19 vaccine booster in the United States?
RE
09/24MIDDAY REPORT : US Stocks Fluctuate as Real Estate, Tech Among Worst Performers; Digital C..
MT
09/24BIONTECH : Mexico To Use Only Pfizer-BioNTech For At-Risk Children
MT
09/24CDC Recommends Booster Shots of Pfizer-BioNTech COVID-19 Vaccine for Older Adults, High..
MT
09/24PFIZER : BioNTech Vaccine Booster Shot Approved by CDC
MT
09/24WALL STREET STOCK EXCHANGE : The day after tomorrow
09/24BIONTECH : Receives a Buy rating from Bryan Garnier
MD
09/24PFIZER : Seeking Full License in Singapore for COVID-19 Shot
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 16 863 M 19 760 M 19 760 M
Net income 2021 8 881 M 10 406 M 10 406 M
Net cash 2021 9 100 M 10 663 M 10 663 M
P/E ratio 2021 8,03x
Yield 2021 -
Capitalization 68 734 M 80 542 M 80 542 M
EV / Sales 2021 3,54x
EV / Sales 2022 2,80x
Nbr of Employees 2 500
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 284,59 €
Average target price 279,55 €
Spread / Average Target -1,77%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE309.08%80 542
GILEAD SCIENCES, INC.22.19%89 259
WUXI APPTEC CO., LTD.34.39%68 685
REGENERON PHARMACEUTICALS32.25%66 425
VERTEX PHARMACEUTICALS-22.31%47 634
BEIGENE, LTD.46.88%35 310